Parenteral nutrition emulsion inhibits CYP3A4 in an iPSC derived liver organoids testing platform

Biochemistry, Genetics and Molecular Biology

• CYP3A4 100%
• Induced Pluripotent Stem Cell 100%
• Lipid 50%
• Hepatocyte 50%
• Interleukin 6 25%
• Olive Tree 25%
• Lipid Emulsion 25%
• Lipid Liver Level 25%
• Solution and Solubility 25%
• Glucose Level 25%
• Drug Megadose 25%
• Upregulation 25%
• Lipid Storage 25%
• Low Birth Weight 25%
• CYP1A2 25%
• TLR4 25%
• RNA 25%

Pharmacology, Toxicology and Pharmaceutical Science

• CYP3A4 100%
• Liver Disease 75%
• Prematurity 50%
• Clinoleic 50%
• Intralipid 25%
• Steatosis 25%
• Parenteral Solution 25%
• Hepatotoxicity 25%
• Cholestasis 25%
• CYP1A2 25%
• Interleukin 6 25%
• Lipid Emulsion 25%
• Toll Like Receptor 4 25%
• Low Birth Weight 25%
• Intestinal Failure 25%

Medicine and Dentistry

• Parenteral Nutrition-Associated Liver Disease 12%